Polymers in Pharmaceutical Additive Manufacturing: A Balancing Act Between Printability and Product Performance
Materials and manufacturing processes share a common purpose of enabling the pharmaceutical product to perform as intended. This review on the role of polymeric materials in additive manufacturing of oral dosage forms, focuses on the interface between the polymer and key stages of the additive manufacturing process, which determine printability.
By systematically clarifying and comparing polymer functional roles and properties for a variety of AM technologies, together with current and emerging techniques to characterize these properties, suggestions are provided to stimulate the use of readily available and sometimes underutilized pharmaceutical polymers in additive manufacturing. We point to emerging characterization techniques and digital tools, which can be harnessed to manage existing trade-offs between the role of polymers in printer compatibility versus product performance.
In a rapidly evolving technological space, this serves to trigger the continued development of 3D printers to suit a broader variety of polymers for widespread applications of pharmaceutical additive manufacturing.
Article information: Rydvikha Govender, Eric Ofosu Kissi, Anette Larsson, Ingunn Tho, Polymers in Pharmaceutical Additive Manufacturing: ABalancing Act Between Printability and Product Performance, Advanced Drug Delivery Reviews, 2021. https://doi.org/10.1016/j.addr.2021.113923.
Find out more about 3D printing and HME here:
